국제계약서 중에서 기술이전 및 독점라이선스 계약서 중 기간, 계약위반 등으로 인한 계 약종료, 계약종료 후 처리 등 TERM AND TERMINATION 조항 샘플Technology Transfer and Exclusive License Agreement • May 10th, 2019
TECHNOLOGY TRANSFER AND EXCLUSIVE LICENSE AGREEMENT between Arbutus Biopharma Corporation and Qilu Pharmaceutical Co., Ltd. December 13, 2021Technology Transfer and Exclusive License Agreement • March 3rd, 2022 • Arbutus Biopharma Corp • Pharmaceutical preparations • Delaware
This Technology Transfer and Exclusive License Agreement (this “Agreement”) is made as of December 13, 2021 (the “Execution Date”), by and between Arbutus Biopharma Corporation, a British Columbia corporation (“Arbutus”), having a place of business at 701 Veterans Circle, Warminster, PA 18974, USA, and Qilu Pharmaceutical Co., Ltd., a company established pursuant to applicable laws and regulations of the People’s Republic of China (“Qilu”), having a place of business at No. 8888 Lvyou Road, Jinan, Shandong 250104 China. Arbutus and Qilu are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
